AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9701971 — intervention group
Group type: EXPERIMENTAL
Intervention: Writing (handwriting)
Number of subjects: 0
Study 9701971 — intervention group
Group type: COMPARATOR
Intervention: Tracing or writing without feedback
Number of subjects: 0
Study 9701971 — intervention group
Group type: COMPARATOR
Intervention: Writing in reverse or random orders
Number of subjects: 0
Study 7718374 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-tetanic burst (PTB) stimulation
Number of subjects: 30
Study 7718374 — intervention group
Group type: COMPARATOR
Intervention: Post-tetanic twitch (PTT) stimulation
Number of subjects: 30
Study 2509910 — intervention group
Group type: EXPERIMENTAL
Intervention: Deprenyl (10 mg per day)
Number of subjects: 800
Study 2509910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800
Study 61122 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide
Number of subjects: 32
Study 61122 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 31315279 — intervention group
Group type: EXPERIMENTAL
Intervention: High-CGA coffee (369 mg CGA/serving)
Number of subjects: 150
Study 31315279 — intervention group
Group type: COMPARATOR
Intervention: Control coffee (35 mg CGA/serving)
Number of subjects: 150
Study 28705592 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (bolus injection of 1.5 mg/kg at induction, continuous infusion of 2 mg/kg/h until end of surgery)
Number of subjects: 80
Study 28705592 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 80
Study 28705592 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 80
Study 24158328 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-size microchip (10.9×1.6 mm)
Number of subjects: 40
Study 24158328 — intervention group
Group type: COMPARATOR
Intervention: Microchip implantation and control treatments
Number of subjects: 40
Study 21157389 — intervention group
Group type: EXPERIMENTAL
Intervention: Instantaneous performance feedback (peak velocity) during squat jump exercises
Number of subjects: 13
Study 21157389 — intervention group
Group type: COMPARATOR
Intervention: No feedback during squat jump exercises
Number of subjects: 13
Study 19476827 — intervention group
Group type: EXPERIMENTAL
Intervention: Duct to mucosa pancreaticojejunostomy
Number of subjects: 197
Study 19476827 — intervention group
Group type: COMPARATOR
Intervention: Invagination pancreaticojejunostomy
Number of subjects: 197
Study 19476827 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 197
Study 19476827 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreas texture
Number of subjects: 197
Study 17189870 — intervention group
Group type: EXPERIMENTAL
Intervention: Premeal insulin lispro + bedtime NPH
Number of subjects: 30
Study 17189870 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily NPH
Number of subjects: 30
Study 15138912 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative neuraxial anesthesia
Number of subjects: 196
Study 15138912 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 196
Study 11472282 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexitone 0.5 mg kg(‐1) combined with remifentanil 1.0 microg kg(‐1)
Number of subjects: 10
Study 11472282 — intervention group
Group type: COMPARATOR
Intervention: Methohexitone 0.75 mg kg(‐1)
Number of subjects: 10
Study 11472282 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 10
Study 9677017 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated plasma total homocysteine concentration (over 11.5 micromol/L)
Number of subjects: 513
Study 9677017 — intervention group
Group type: COMPARATOR
Intervention: Plasma total homocysteine concentration below 11.5 micromol/L
Number of subjects: 513
Study 8017450 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic medroxyprogesterone plus calcium carbonate (n = 16)
Number of subjects: 61
Study 8017450 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic medroxyprogesterone with calcium placebo (n = 16)
Number of subjects: 61
Study 8017450 — intervention group
Group type: COMPARATOR
Intervention: Placebo medroxyprogesterone with active calcium (n = 15)
Number of subjects: 61
Study 8017450 — intervention group
Group type: COMPARATOR
Intervention: Both medroxyprogesterone and calcium placebos (n = 14)
Number of subjects: 61
Study 1851894 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg of sumatriptan succinate subcutaneously
Number of subjects: 1104
Study 1851894 — intervention group
Group type: EXPERIMENTAL
Intervention: Second injection of sumatriptan (n = 187)
Number of subjects: 1104
Study 1851894 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 370)
Number of subjects: 1104
Study 1851894 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 335)
Number of subjects: 1104
Study 795496 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of lincomycin
Number of subjects: 100
Study 795496 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lincomycin)
Number of subjects: 100
Study 31399915 — intervention group
Group type: EXPERIMENTAL
Intervention: Early combination therapy with gentamicin (treatment started within 48 hours of culture results and continued for a minimum of 7 days)
Number of subjects: 190
Study 31399915 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with penicillin-based treatment
Number of subjects: 190
Study 31399915 — intervention group
Group type: COMPARATOR
Intervention: Other treatments (not specified)
Number of subjects: 190
Study 28686664 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dose of hydrocortisone (0.2-0.3 mg HC/kg body weight/day)
Number of subjects: 46
Study 28686664 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose of hydrocortisone (0.4-0.6 mg HC/kg body weight/day)
Number of subjects: 46
Study 25085709 — intervention group
Group type: EXPERIMENTAL
Intervention: COMP (with opponent avatar)
Number of subjects: 15
Study 25085709 — intervention group
Group type: COMPARATOR
Intervention: SELF (with self avatar)
Number of subjects: 15
Study 25085709 — intervention group
Group type: COMPARATOR
Intervention: DO (no avatar)
Number of subjects: 15
Study 23507972 — intervention group
Group type: EXPERIMENTAL
Intervention: Blink Intensive Tears (RE)
Number of subjects: 20
Study 23507972 — intervention group
Group type: EXPERIMENTAL
Intervention: Optive Eye Drops (LE)
Number of subjects: 20
Study 23507972 — intervention group
Group type: EXPERIMENTAL
Intervention: Both eyedrops after 21 days
Number of subjects: 20
Study 21797835 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 132
Study 21797835 — intervention group
Group type: EXPERIMENTAL
Intervention: Light exposure
Number of subjects: 132
Study 21797835 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (walking, light, and sleep education)
Number of subjects: 132
Study 21797835 — intervention group
Group type: COMPARATOR
Intervention: Contact control
Number of subjects: 132
Study 21797835 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking and light exposure adherence (4 d/wk)
Number of subjects: 132
Study 19855319 — intervention group
Group type: EXPERIMENTAL
Intervention: Deadlift (5 repetitions at 5 repetitions maximum)
Number of subjects: 12
Study 19855319 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuck jump (5 repetitions)
Number of subjects: 12
Study 19855319 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric MVC knee extensions (3 repetitions for 3 s)
Number of subjects: 12
Study 19855319 — intervention group
Group type: COMPARATOR
Intervention: Control warm up
Number of subjects: 12
Study 16892789 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg)
Number of subjects: 51
Study 16892789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 16675760 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard mood stabilizers (lithium, valproate, or carbamazepine)
Number of subjects: 500
Study 16675760 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 500
Study 16675760 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel anticonvulsants
Number of subjects: 500
Study 16675760 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation neuroleptics
Number of subjects: 500
Study 16675760 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepines
Number of subjects: 500
Study 16675760 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard mood stabilizer monotherapy
Number of subjects: 500
Study 14570781 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopexamine at the rate of 0.25 microg kg(‐1) min(‐1)
Number of subjects: 100
Study 14570781 — intervention group
Group type: COMPARATOR
Intervention: Saline 0.9% (control)
Number of subjects: 100
Study 10614791 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care qualitative troponin T test at enrollment
Number of subjects: 12666
Study 10614791 — intervention group
Group type: COMPARATOR
Intervention: Alteplase or reteplase (thrombolysis treatment)
Number of subjects: 12666
Study 7699662 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 3006
Study 7699662 — intervention group
Group type: EXPERIMENTAL
Intervention: Tender point counts
Number of subjects: 3006
Study 7699662 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased pain threshold
Number of subjects: 3006
Study 2147930 — intervention group
Group type: EXPERIMENTAL
Intervention: sulbactam-ampicillin
Number of subjects: 40
Study 2147930 — intervention group
Group type: COMPARATOR
Intervention: cefoxitin
Number of subjects: 40
Study 7204284 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral parent training
Number of subjects: 36
Study 7204284 — intervention group
Group type: EXPERIMENTAL
Intervention: Client-centered parent counseling
Number of subjects: 36
Study 7204284 — intervention group
Group type: COMPARATOR
Intervention: Wait control group
Number of subjects: 36
Study 30825082 — intervention group
Group type: EXPERIMENTAL
Intervention: Project SEARCH plus ASD Supports (PS + ASD)
Number of subjects: 156
Study 30825082 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 156
Study 30825082 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 156
Study 29921041 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboxytherapy using carbon dioxide (CO2) injection
Number of subjects: 45
Study 29921041 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal injection of autologous platelet-rich plasma (PRP)
Number of subjects: 45
Study 29921041 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripolar radiofrequency (RF)
Number of subjects: 45
Study 29921041 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 45
Study 28905475 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine bone mineral (bbm) grafting
Number of subjects: 24
Study 28905475 — intervention group
Group type: COMPARATOR
Intervention: Naturally healing sockets (nat)
Number of subjects: 24
Study 28905475 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine bone mineral (bbm) in molars
Number of subjects: 24
Study 28905475 — intervention group
Group type: COMPARATOR
Intervention: Naturally healing sockets (nat) in molars
Number of subjects: 24
Study 28905475 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine bone mineral (bbm) in premolars
Number of subjects: 24
Study 28905475 — intervention group
Group type: COMPARATOR
Intervention: Naturally healing sockets (nat) in premolars
Number of subjects: 24
Study 25239018 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily pain assessment using Pain Assessment in Advanced Dementia
Number of subjects: 103
Study 25239018 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of average daily pain
Number of subjects: 103
Study 23620782 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 67
Study 23620782 — intervention group
Group type: COMPARATOR
Intervention: Healthy Control (Replication Sample)
Number of subjects: 67
Study 23620782 — intervention group
Group type: COMPARATOR
Intervention: Healthy Control (Main Sample)
Number of subjects: 67
Study 21949163 — intervention group
Group type: EXPERIMENTAL
Intervention: EMR reminder
Number of subjects: 0
Study 21949163 — intervention group
Group type: EXPERIMENTAL
Intervention: EMR reminder plus panel manager
Number of subjects: 0
Study 21949163 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 19702706 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate cataract surgery
Number of subjects: 56
Study 19702706 — intervention group
Group type: COMPARATOR
Intervention: Deferred cataract surgery
Number of subjects: 56
Study 17481879 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10mg for 12 weeks
Number of subjects: 75
Study 17481879 — intervention group
Group type: COMPARATOR
Intervention: Budesonide 1600 mcg/day for 12 weeks
Number of subjects: 75
Study 15018343 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary rounds (IRs)
Number of subjects: 84
Study 15018343 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 84
Study 9257206 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 106
Study 9257206 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 106
Study 8302788 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative radiotherapy (IORT)
Number of subjects: 26
Study 8302788 — intervention group
Group type: COMPARATOR
Intervention: External beam radiotherapy (EBRT)
Number of subjects: 26
Study 8302788 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (for stage I patients)
Number of subjects: 26
Study 8302788 — intervention group
Group type: EXPERIMENTAL
Intervention: Local disease control
Number of subjects: 26
Study 3771951 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized grass extract immunotherapy
Number of subjects: 0
Study 3771951 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no standardized grass extract)
Number of subjects: 0
Study 28025967 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate tablet 50 mg (Jinge®, Test)
Number of subjects: 32
Study 28025967 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil citrate tablet 100 mg (Viagra®, Reference)
Number of subjects: 32
Study 31026037 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhancing Trauma Awareness course (6 sessions over 12 weeks)
Number of subjects: 96
Study 31026037 — intervention group
Group type: COMPARATOR
Intervention: No course (control group)
Number of subjects: 96
Study 31026037 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhancing Trauma Awareness course
Number of subjects: 96
Study 31026037 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group feedback from intervention teachers
Number of subjects: 96
Study 28965797 — intervention group
Group type: EXPERIMENTAL
Intervention: LopiGLIK®
Number of subjects: 359
Study 28965797 — intervention group
Group type: COMPARATOR
Intervention: Armolipid Plus®
Number of subjects: 359
Study 26087573 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium abutment
Number of subjects: 47
Study 26087573 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold-hue titanium abutment
Number of subjects: 47
Study 26087573 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia abutment
Number of subjects: 47
Study 26087573 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 47
Study 23714755 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-absorbing catgut (FAC) sutures
Number of subjects: 98
Study 23714755 — intervention group
Group type: COMPARATOR
Intervention: Nylon (NYL) sutures
Number of subjects: 98
Study 21093060 — intervention group
Group type: EXPERIMENTAL
Intervention: Real TMS (LF-TMS)
Number of subjects: 34
Study 21093060 — intervention group
Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 34
Study 19101755 — intervention group
Group type: EXPERIMENTAL
Intervention: 500,000 IU loading dose
Number of subjects: 63
Study 19101755 — intervention group
Group type: EXPERIMENTAL
Intervention: 500,000 IU loading dose + 50,000 IU/month
Number of subjects: 63
Study 19101755 — intervention group
Group type: EXPERIMENTAL
Intervention: 50,000 IU/month
Number of subjects: 63
Study 19101755 — intervention group
Group type: COMPARATOR
Intervention: Control group (baseline 25OHD > 50 nmol/L)
Number of subjects: 63
Study 16757922 — intervention group
Group type: EXPERIMENTAL
Intervention: Active food challenge
Number of subjects: 15
Study 16757922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 15093843 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. CaCl(2) pre-treatment
Number of subjects: 78
Study 15093843 — intervention group
Group type: COMPARATOR
Intervention: Placebo pre-treatment
Number of subjects: 78
Study 11952848 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b and ribavirin for 6 months
Number of subjects: 61
Study 11952848 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b and ribavirin for 12 months
Number of subjects: 61
Study 11952848 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b and ribavirin for both durations
Number of subjects: 61
Study 9848042 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC) (approximately 10 micrograms/kg)
Number of subjects: 14
Study 9848042 — intervention group
Group type: COMPARATOR
Intervention: Oral hydromorphone (60 micrograms/kg)
Number of subjects: 14
Study 9848042 — intervention group
Group type: COMPARATOR
Intervention: Both OTFC and hydromorphone
Number of subjects: 14
Study 8011819 — intervention group
Group type: EXPERIMENTAL
Intervention: Meglumine antimonate for 20 days
Number of subjects: 66
Study 8011819 — intervention group
Group type: EXPERIMENTAL
Intervention: Meglumine antimonate for 10 days
Number of subjects: 66
Study 8011819 — intervention group
Group type: EXPERIMENTAL
Intervention: Meglumine antimonate for 10 days plus alternate-day injections of interferon-gamma
Number of subjects: 66
Study 2638182 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% triclosan toothpaste
Number of subjects: 14
Study 2638182 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% triclosan toothpaste with PVM/MA copolymer
Number of subjects: 14
Study 2638182 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% triclosan toothpaste without PVM/MA copolymer
Number of subjects: 14
Study 2638182 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine rinse
Number of subjects: 14
Study 2638182 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial fluoride toothpaste
Number of subjects: 14
Study 2638182 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 14
Study 2638182 — intervention group
Group type: COMPARATOR
Intervention: Control paste
Number of subjects: 14
Study 125578 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate and haloperidol
Number of subjects: 6
Study 125578 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 6
Study 125578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 125578 — intervention group
Group type: COMPARATOR
Intervention: Lithium carbonate
Number of subjects: 6
Study 30799485 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based cognitive-behavioral therapy (T-CBT)
Number of subjects: 397
Study 30799485 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 397
Study 29282005 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine LAM testing
Number of subjects: 187
Study 29282005 — intervention group
Group type: COMPARATOR
Intervention: Sputum production
Number of subjects: 187
Study 29282005 — intervention group
Group type: EXPERIMENTAL
Intervention: Sputum-scarce patients
Number of subjects: 187
Study 26086603 — intervention group
Group type: EXPERIMENTAL
Intervention: High loading dose of Rosuvastatin before PCI (n = 264)
Number of subjects: 528
Study 26086603 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (n = 264)
Number of subjects: 528
Study 26086603 — intervention group
Group type: EXPERIMENTAL
Intervention: High loading dose of Rosuvastatin before PCI
Number of subjects: 528
Study 26086603 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 528
Study 22961230 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-based smoking cessation support
Number of subjects: 1000
Study 21622634 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacteriostatic saline solution containing 0.9% benzyl alcohol before lidocaine infiltration
Number of subjects: 45
Study 21622634 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine injection without prior saline injection
Number of subjects: 45
Study 19323394 — intervention group
Group type: EXPERIMENTAL
Intervention: Palodent matrix system
Number of subjects: 101
Study 19323394 — intervention group
Group type: COMPARATOR
Intervention: Circumferential matrix system
Number of subjects: 101
Study 16427545 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (100 mg/kg before skin incision followed by 1 g/hour continuous infusion until chest closure, 10 g in cardiopulmonary bypass circuit)
Number of subjects: 100
Study 16427545 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 16427545 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid
Number of subjects: 100
Study 15262625 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical displacement during pointing task with delayed visual feedback
Number of subjects: 24
Study 15262625 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of head-shoulder posture while viewing optically displaced field
Number of subjects: 24
Study 15262625 — intervention group
Group type: EXPERIMENTAL
Intervention: First-trial adaptation
Number of subjects: 24
Study 10971859 — intervention group
Group type: EXPERIMENTAL
Intervention: EPD (immunotherapy)
Number of subjects: 50
Study 10971859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 8790757 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular training (VT) with drug therapy
Number of subjects: 0
Study 8790757 — intervention group
Group type: COMPARATOR
Intervention: Medication alone (Control)
Number of subjects: 0
Study 1617762 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive physical exercise and low-fat diet (minimum 2 hr/wk group training, 20 min/d home exercise)
Number of subjects: 113